EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin

Hossein Kalanie, Ali Amini Harandi, Shapoor Alidaei, Daryoosh Heidari, Saeed Shahbeigi, Mehdi Ghorbani

Thrombosis · 2011

DOI: 10.1155/2011/785459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis, 2011. Verfasst von Hossein Kalanie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study was designed to examine the possible role of high-dose intravenous methylprednisolone (IVMP) in the development of venous thrombosis (VT). The cerebral one anecdotally had been reported in patients with relapsing remitting multiple sclerosis (RRMS) in acute attacks and the possible preventive role of enoxaparin. Material and Methods . From a pool of 520 patients, 388 patients with definite RRMS who fulfilled entry characteristics were selected and randomly received either a 5-day course of daily 1 gr IVMP or the aforementioned plus 5 days of daily subcutaneous 40 units of enoxaparin according to a predefined protocol.

Results

Mean age, gender ratio, mean relapse rate, and EDSS were similar in both groups of patients ( P > 0.05). Finally, 366 patients remained in the study. Of 188 patients treated with IVMP with 855 relapses, 5 developed VT (0.37% per patient per year and 0.58% per each course of IVMP) within 3 to 15 days of starting therapy. None of the 178 patients who experienced 809 relapses who received IVMP plus enoxaparin developed such complications.

Conclusion

The study implies that high-dose IVMP in MS exacerbation may increase the risk of VT and prophylactic anticoagulant treatment in this setting is warranted.

Autor:innen und Institutionen

  • Mehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran.

Zitieren

APA

Kalanie, H., Harandi, A. A., Alidaei, S., Heidari, D., Shahbeigi, S., & Ghorbani, M. (2011). Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin. Thrombosis. https://doi.org/10.1155/2011/785459

Vancouver

Kalanie H, Harandi AA, Alidaei S, Heidari D, Shahbeigi S, Ghorbani M. Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin. Thrombosis. 2011. doi:10.1155/2011/785459

BibTeX
@article{Kalanie2011,
  author = {Kalanie, Hossein and Harandi, Ali Amini and Alidaei, Shapoor and Heidari, Daryoosh and Shahbeigi, Saeed and Ghorbani, Mehdi},
  title = {Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin},
  journal = {Thrombosis},
  year = {2011},
  doi = {10.1155/2011/785459}
}
Kostenlos starten →